04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
ASIC has provided long-awaited confirmation of its policy position with regard to applications for r...
Read More >
Restaurant Owner and Manager Sexually Harassed Female Employees, Federal Agency Charged - FORT LAU...
Read More >
For the first time in its history, the U.S. Committee on Foreign Investment in the United States (CF...
Read More >
State and local governments are increasingly regulating the workplace. Although it is not possible t...
Read More >
Many compliance officers over the years have wished for the day when what we do is at the forefront ...
Read More >
A number of regulators across the globe responded to recent market volatility by introducing tempora...
Read More >